[HTA Rapid report-Yervoy (malignant pleural mesothelioma - MPM)]
Center for Drug Evaluation
Record ID 32018013832
Chinese (Mandarin)
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://www.cde.org.tw/media/aknkulp2/11302_6_%E8%A8%8E%E8%AB%96%E6%A1%88%E7%AC%AC4%E6%A1%88_yervoy-%E6%83%A1%E6%80%A7%E8%82%8B%E8%86%9C%E9%96%93%E7%9A%AE%E7%98%A4mpm.pdf?mediaDL=true
English language abstract:
There is no English language summary available
Publication Type:
Not Assigned
MeSH Terms
- Mesothelioma, Malignant
- Mesothelioma
- Ipilimumab
- Antineoplastic Agents, Immunological
- Immune Checkpoint Inhibitors
Contact
Organisation Name:
Center for Drug Evaluation
Contact Address:
3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name:
Li Ying (Grace) Huang
Contact Email:
lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.